Protocol summary

Summary
Objective of the study is comparison of 30 min- and 5 min- ultraviolet radiation in cross-linking treatment among keratoconic cornea. 30 patients with advanced progressive bilateral keratoconus were enrolled after signing written consent form. The eyes were randomly assigned to conventional (30 min) and new method (5 min) of radiation on the basis of balance blocked randomization. All routine clinical examinations and paraclinical tests were performed for the patients before the operation. Then they were examined 1, 3 and 6 months after the operation, and following tests were conducted for them: visual acuity, refraction, corneal biomechanical assessment, endothelial cell count, and corneal topography. Patients do not pay for these tests. Finally, after comparing the two procedures, the preferred method is introduced.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT201207244333N1
Registration date: 2012-08-30, 1391/06/09
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2012-08-30, 1391/06/09
Registrant information
Name
Soheila Asgari
Name of organization / entity
Noor eye hospital
Country
Iran (Islamic Republic of)
Phone
+98 21 8865 1515
Email address
sasgari@noorvision.com
Recruitment status
Recruitment complete
Funding source
Research funding in Noor eye hospital
Expected recruitment start date
2012-08-22, 1391/06/01
Expected recruitment end date
2013-02-18, 1391/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
comparison of 30 minutes and 5 minutes collagen cross-linking in patients with keratoconus
Public title
New treatment of keratoconus with UV
Purpose
Treatment
Inclusion/Exclusion criteria
inclusion criteria: keratometry less than 60 diopter; central corneal thickness of 400 microns or more; keratoconus progression in the past 12 months documented as at least one D increase in maximum keratometry, or manifest cylinder; Bilateral surgery Exclusion criteria: diabetes and other systematic disease; use of corticosteroid and immunosupressive drugs in the past 6 months
Age
From 15 years old to 35 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Noor eye hospital
Street address
#96 Esfandiar Blvd., Vali’asr Ave.
City
Tehran
Postal code
1968653111
Approval date
2012-07-26, 1391/05/05
Ethics committee reference number
م/757

Health conditions studied

1

Description of health condition studied
Keratoconus
ICD-10 code
H18.6
ICD-10 code description
keratoconus

Primary outcomes

1

Description
corneal biomechanical assay
Timepoint
pre op, 1m, 3m and 6m after surgery
Method of measurement
Cornea status is evaluated by Ocular Response Analyzer (ORA), confoscan, and endothelial cell count (ECC)

Secondary outcomes

1

Description
Refraction
Timepoint
pre op, 1m, 3m and 6m after surgery
Method of measurement
autorefractometer

2

Description
Keratometry
Timepoint
pre op, 1m, 3m and 6m after surgery
Method of measurement
Pentacam

3

Description
Visual acuity
Timepoint
pre op, 1m, 3m and 6m after surgery
Method of measurement
Snellen chart

Intervention groups

1

Description
Intervention name: 5 min-UV radiation in corneal cross-linking Intervention description: After local anesthesia with Proparacaine hydrochloride 0.5% eye drop, 3 or 4 vertical strips about 2 mm wide remove from the central 8-9 mm corneal epithelium. Then, riboflavin 0.1% drop in dextra 20% is instilled onto the cornea every 3 minutes for half an hour (a total of 10 times). At the end of this stage, the patient is examined by the slit lamp to ensure the presence of riboflavin and yellow tindall in the anterior chamber. Then, ultraviolet irradiation at a wavelength of 370 nanometer, a width of 9 mm, power 3mW/cm2 and a distance of 5cm is started. In interventional group, Ultraviolet irradiation is continued for 5 minutes. At the end of irradiation, the corneal surface is rinsed with sterile balanced saline solution, a soft bandage contact lens was placed. Chloramphenicol and betamethasone eye drop will be prescribed at discharge.
Category
Treatment - Surgery

2

Description
The control intervention: 30 min-UV radiation in corneal cross-linking (routin treatment) Control intervention description: After local anesthesia with Proparacaine hydrochloride 0.5% eye drop, 3 or 4 vertical strips about 2 mm wide remove from the central 8-9 mm corneal epithelium. Then, riboflavin 0.1% drop in dextra 20% is instilled onto the cornea every 3 minutes for half an hour (a total of 10 times). At the end of this stage, the patient is examined by the slit lamp to ensure the presence of riboflavin and yellow tindall in the anterior chamber. Then, ultraviolet irradiation at a wavelength of 370 nanometer, a width of 9 mm, power 3mW/cm2 and a distance of 5cm is started. In control group, Ultraviolet irradiation is continued for 30 minutes. At the end of irradiation, the corneal surface is rinsed with sterile balanced saline solution, a soft bandage contact lens was placed. Chloramphenicol and betamethasone eye drop will be prescribed at discharge.
Category
Treatment - Surgery

Recruitment centers

1

Recruitment center
Name of recruitment center
Noor eye hospital
Full name of responsible person
Dr Hassan Hashemi, fellowship in cornea and anterior segment, professor
Street address
#96 Esfandiar Blvd., Vali’asr Ave.
City
Tehran

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Noor eye hospital
Full name of responsible person
DR Hassan Hashemi
Street address
#96 Esfandiar Blvd., Vali’asr Ave.
City
Tehran
Grant name
امور پژوهشی بیمارستان نور
Grant code / Reference number
91-0504
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Noor eye hospital
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Noor eye hospital
Full name of responsible person
Soheila Asgari
Position
MS in Epidemiology
Other areas of specialty/work
Street address
#96 Esfandiar Blvd., Vali’asr Ave.
City
Tehran
Postal code
1968653111
Phone
+98 21 8240 1621
Fax
+98 21 8865 1514
Email
soheilaasgari@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Noor ophthalmology research center, Noor eye hospital
Full name of responsible person
Hassan Hashemi
Position
fellowship in cornea and anterior segment
Other areas of specialty/work
Street address
#96 Esfandiar Blvd., Vali’asr Ave.
City
Tehran
Postal code
1968653111
Phone
+98 21 8865 1515
Fax
+98 21 8865 1514
Email
hhashemi@noorvision.com
Web page address

Person responsible for updating data

Contact

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...